Yüklüyor......
A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism
BACKGROUND: CAD-31 is an Alzheimer’s disease (AD) drug candidate that was selected on the basis of its ability to stimulate the replication of human embryonic stem cell-derived neural precursor cells as well as in APPswe/PS1ΔE9 AD mice. To move CAD-31 toward the clinic, experiments were undertaken t...
Kaydedildi:
| Yayımlandı: | Alzheimers Res Ther |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5513091/ https://ncbi.nlm.nih.gov/pubmed/28709449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0277-3 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|